Speaker illustration

Doctor Alex Byrne

Godalming (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardiovascular complications in cardio-oncology: risk assessment

Thumbnail

OCT versus angiography for post insertion assessment of everolimus-eluting bioresorbale vascular scaffolds and the prevention of major adverse cardiovascular events.

Event: ESC Congress 2016

Topic: PCI / stents: devices and technique

Session: Technical aspects of bioresorbable scaffold-based PCI

Thumbnail